About this Research Topic
One emerging approach is personalized medicine. Personalized medicine is distinct from the traditional ‘one-size-fits-all’ medicine in that it is based on the unique molecular and genetic profile of an individual. Individual characterization relies on comprehensive analyses of genomics, proteomics, metabolomics, epigenetics, as well as environmental factors. In addition, bioinformatics can be utilized to evaluate the relationship between those factors and the disease status.
We would like to acknowledge and credit Dr. Chunya Lu has acted as coordinator and have contributed to the preparation of the proposal for this Research Topic.
We welcome Original Research, Reviews, Mini Review, Perspective, Methods, Protocols, Case Report, Clinical Trial and Opinion on the following topics (but not limited to):
• molecular mechanisms of lung cancer chemoresistance
• personalized medicine for lung cancer patients
• new prognosis/therapeutic biomarkers, targets, and strategies for lung cancer patients
Keywords: Lung cancer, Chemotherapy, Drug Resistance, Chemoresistance, Personalized chemotherapy, Precision chemotherapy
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.